These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35854963)

  • 1. Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil.
    Jeang LJ; Shah AS; Hammer JD; Tuli SS
    Digit J Ophthalmol; 2022; 28(8):34-37. PubMed ID: 35854963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil.
    Chen H; McMillin JC; Frankfort BJ; Al-Mohtaseb Z
    J Glaucoma; 2020 Nov; 29(11):e124-e126. PubMed ID: 32826765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reticular Corneal Edema or Corneal Honeycombing in Eyes Treated With Netarsudil: A Case Series.
    Moumneh K; Sheybani A; Fellman RL; Godfrey DG; Grover DS
    J Glaucoma; 2020 Jul; 29(7):607-610. PubMed ID: 32398584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series.
    Wisely CE; Liu KC; Gupta D; Carlson AN; Asrani SG; Kim T
    Am J Ophthalmol; 2020 Sep; 217():20-26. PubMed ID: 32289295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2.
    Wisely CE; Sheng H; Heah T; Kim T
    Adv Ther; 2020 Mar; 37(3):1114-1123. PubMed ID: 31981106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible Corneal Endothelial Abnormalities With Netarsudil.
    Tanna AP; Esfandiari H; Teramoto K
    J Glaucoma; 2020 Jun; 29(6):e41-e43. PubMed ID: 32224803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2.
    Asrani S; Bacharach J; Holland E; McKee H; Sheng H; Lewis RA; Kopczynski CC; Heah T
    Adv Ther; 2020 Apr; 37(4):1620-1631. PubMed ID: 32166538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient Reticular Cystic Corneal Epithelial Edema With Topical Netarsudil: A Case Series and Review.
    LoBue SA; Moustafa GA; Vu A; Amin M; Nguyen T; Goyal H
    Cornea; 2021 Aug; 40(8):1048-1054. PubMed ID: 33369939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Netarsudil-associated reticular corneal epithelial edema.
    Tran JA; Jurkunas UV; Yin J; Davies EC; Sola-Del Valle DA; Chen TC; Lin MM
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101287. PubMed ID: 35146185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting.
    Zaman F; Gieser SC; Schwartz GF; Swan C; Williams JM
    Curr Med Res Opin; 2021 Jun; 37(6):1011-1020. PubMed ID: 33733980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netarsudil-Associated Reticular Corneal Epithelial Edema with Raised Intraocular Pressure.
    Liu KC; Gupta D
    Ophthalmol Glaucoma; 2019; 2(3):166. PubMed ID: 32672585
    [No Abstract]   [Full Text] [Related]  

  • 12. Netarsudil-related Eyelid Wound Dehiscence.
    Kim HM; Tran AQ; Yang C; Dagi Glass LR
    J Glaucoma; 2021 Feb; 30(2):206-208. PubMed ID: 33861552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
    Serle JB; Katz LJ; McLaurin E; Heah T; Ramirez-Davis N; Usner DW; Novack GD; Kopczynski CC;
    Am J Ophthalmol; 2018 Feb; 186():116-127. PubMed ID: 29199013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension.
    Batra M; Gupta S; Nair AB; Dhanawat M; Sandal S; Morsy MA
    Eur J Ophthalmol; 2021 Sep; 31(5):2237-2244. PubMed ID: 33843288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma.
    Mehta AA; Kanu LN; Sood-Mendiratta S; Quinones R; Hawkins A; Lehrer RA; Malhotra K; Papas R; Hillman D; Wilensky JT; Aref AA; Vajaranant TS; Edward DP
    Eur J Ophthalmol; 2022 Jan; 32(1):322-326. PubMed ID: 33653172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two pediatric cases of reticular corneal epithelial edema associated with netarsudil.
    Guzman Aparicio MA; Liebman DL; Chodosh J; Freitag SK; Kazlas M; Mai DD; Marando CM; Mukai S; Wu AM; Chen TC
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101638. PubMed ID: 35813588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic adjunctive usage of netarsudil: A retrospective chart review from a tertiary care center.
    Goergen NS; Gagrani M; Gulati V; Ghate D
    Indian J Ophthalmol; 2022 Aug; 70(8):2906-2910. PubMed ID: 35918941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot Study of Corneal Clearance With the Use of a Rho-Kinase Inhibitor After Descemetorhexis Without Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy.
    Davies E; Jurkunas U; Pineda R
    Cornea; 2021 Jul; 40(7):899-902. PubMed ID: 33758139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study.
    Sit AJ; Gupta D; Kazemi A; McKee H; Challa P; Liu KC; Lopez J; Kopczynski C; Heah T
    Am J Ophthalmol; 2021 Jun; 226():262-269. PubMed ID: 33524367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Series: Novel Utilization of Rho-Kinase Inhibitor for the Treatment of Corneal Edema.
    Davies E
    Cornea; 2021 Jan; 40(1):116-120. PubMed ID: 33269892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.